Most skincare marketing gets vague on purpose, because vague feels safe. It isn't. It's the version most likely to convert badly, and the one most likely to get flagged.
A UK skincare product is legally a cosmetic, not a medicine, unless it holds a specific licence, and that single fact sets the ceiling on every claim a brand can make in ads, on-pack copy, and on its website. Cosmetic claims can describe an appearance-level effect, such as visibly reducing the look of something on the skin's surface. They cannot claim to treat, cure, or prevent a disease, that is medicinal territory, reserved for products licensed by the MHRA or under an EMA framework. The Advertising Standards Authority enforces this line through the CAP Code, and every objective claim needs evidence held before it is published, not produced after a complaint arrives. The brands that market well inside this space do not write softer copy. They write sharper, more specific copy that stays on the cosmetic side of the line.
What "regulated" actually means for a UK skincare brand
"Regulated" doesn't mean skincare sits in some special legal danger zone. It means the product category has a defined boundary, and marketing has to stay inside it. A skincare product is classed as a cosmetic under UK cosmetics regulation unless it's licensed as a medicine by the MHRA, or falls under an EU/EMA medicinal framework. Almost no skincare brand holds that licence, and almost none needs to. The boundary just means the claims have to match the classification: a cosmetic can talk about how skin looks, not about diagnosing, treating, or preventing a medical condition.
The Advertising Standards Authority is the body that enforces this in the UK, through the CAP Code (the rules that govern non-broadcast advertising, including websites, social ads, and email). A brand doesn't need a lawyer on retainer to stay inside the lines. It needs marketing that treats the boundary as a creative constraint from the first brief, not a compliance check bolted on at the end. Established brands that market for beauty and skincare tend to build this discipline into how the copy gets written in the first place, not into a review step that happens after the ad is already designed.
Cosmetic claims vs. medicinal claims: the line that decides what you can say
The clearest version of the rule sits in the CAP Code's section on medicines, medical devices, and beauty products (Section 12). Rule 12.1 states that medicinal or medical claims and indications may only be made for a product licensed by the MHRA or under an EMA framework, and defines a medicinal claim as one that says a product can be used to diagnose, treat, or prevent a disease in humans. A cosmetic can carry a secondary claim about a preventative action, but that claim still needs evidence, and it can never extend to treating a disease. (Source: CAP Code Section 12.)
Rule 12.7 pushes this further: references to relieving symptoms or reducing the superficial signs of ageing are acceptable if a brand can substantiate them, but unqualified words like "cure" or "rejuvenation" are not generally acceptable for cosmetic products. That's a useful gut check while writing copy: if the word implies the product fixes a medical problem rather than changes how skin appears, it's probably crossed the line.
In practice, this means a skincare brand can say a serum visibly reduces the look of fine lines. It cannot say the serum treats or reverses ageing, because ageing itself isn't a disease and "reverses" implies a medical-grade fix the evidence almost never supports. That gap isn't subtle once you see it, but it's the exact gap most skincare copy blurs, usually by accident, sometimes because "reverses ageing" tests better in a swipe file borrowed from a competitor under a different regulatory system.
The specific CAP Code rules that trip skincare brands up
Three rules do most of the work, and they're worth knowing by number, not just by feel.
- Rule 12.1 (evidence + licensing): objective claims must be backed by evidence, and medicinal claims are reserved for licensed products. This is the rule that separates "cosmetic" copy from "medicine" copy.
- Rule 12.7 (unqualified claims): references to relieving symptoms or to the superficial signs of ageing are acceptable if they can be substantiated. It's the unqualified version that fails: words like "cure" and "rejuvenation" are not generally acceptable, especially for cosmetic products. The rule doesn't ban the territory, it bans the unsubstantiated absolute.
- Rule 3.7 (hold the evidence first): from the CAP Code's misleading advertising section, marketers must hold documentary evidence before a claim goes live, not scramble to find it after a challenge. (Source: CAP Code Section 3.)
One more rule worth knowing if a brand's claims lean on how a product is used: Rule 12.22 says claims about a cosmetic's action on skin must distinguish what the product itself does from any effect that comes from how it's applied, such as massage.
A one-line disclaimer: this article is general marketing guidance, not legal advice. A brand operating in this space should get its specific claims checked by a qualified regulatory or legal adviser before publishing.
Why the compliant version usually converts better than the vague one
The instinct when a brand gets nervous about regulation is to soften everything into vagueness: "amazing results," "transform your skin," "the secret to glowing skin." That instinct is backwards. Vague claims read as marketing noise, because every skincare ad on a feed says some version of the same thing, and shoppers have learned to scroll past it.
A specific, evidence-backed appearance claim does the opposite. "Visibly reduces the look of dullness within four weeks, tested on a panel of real users" gives a shopper something to evaluate, not just believe. It reads as more credible precisely because it's narrower than the vague version next to it in the feed. Specificity is a conversion lever independent of the regulatory requirement to have it: the ASA forces evidence, and evidence is what makes copy sound trustworthy in the first place.
This is the actual differentiator: not writing softer copy to stay safe, but writing sharper, evidence-anchored copy that already sits on the right side of the cosmetic/medicinal line. The brands that get flagged by the ASA are usually the ones that reached for the biggest unqualified claim because it felt punchier in the moment. The brands that convert well and stay compliant are usually making a narrower claim, stated with more confidence, because they can actually back it.
How to build converting copy inside the lines
The practical version of this looks like a single process, not two separate ones (write the ad, then check it's legal).
Start from the evidence, not the headline. Before a claim gets written, know what the product's testing, panel data, or formulation evidence actually supports. That evidence sets the ceiling on the claim, and it's far cheaper to know that ceiling before the creative brief than after the ad is already in review.
Write the sharpest honest claim available. Inside that ceiling, push for specificity: a number, a timeframe, a described mechanism ("visibly reduces the look of," not "eliminates"). This is where how we write inside a brand's compliance lines earns its keep: the same pass that writes the hook also checks it against the appearance-level line, so nothing gets built around a claim that has to be pulled later.
Review before it's live, not after a complaint. CAP Code Rule 3.7 is explicit that evidence has to be held before publishing. Building that review into production, rather than treating it as an afterthought once a campaign is already spending, keeps a skincare brand's marketing fast and safe.
We know what a skincare brand is allowed to claim in the UK, and we write copy that converts inside those lines. That's the specific capability, built from operating inside regulated-claims discipline on real campaigns, not a generic content-writing service that happens to also cover skincare.
Who this is for (and who it isn't)
This is built for an established UK skincare or beauty brand with real formulation evidence on file, that wants marketing which won't get pulled or flagged six months into a campaign. If regulatory anxiety has been quietly softening your copy into forgettable claims, that's the gap this closes.
It isn't for a brand that hasn't worked out what its own product does, or is hoping copy can paper over evidence that doesn't exist. No agency, ours included, can write a compliant claim a product can't support.
FAQ
Is a skincare product a cosmetic or a medicine under UK rules? A skincare product is a cosmetic unless it's specifically licensed as a medicine by the MHRA or under an EU/EMA medicinal framework. Almost no skincare brand holds that licence, so almost all skincare marketing has to stay within cosmetic-level, appearance-based claims.
What's the difference between a cosmetic claim and a medicinal claim? A cosmetic claim describes a visible, surface-level effect, like reducing the look of something on the skin. A medicinal claim says a product can diagnose, treat, or prevent a disease, and under CAP Code Rule 12.1, that language is reserved for licensed medicinal products.
Can a skincare brand ever say a product "cures" something? Generally no. CAP Code Rule 12.7 states that unqualified claims such as "cure" and "rejuvenation" are not generally acceptable, especially for cosmetic products. The word implies a medical-grade fix the evidence almost never supports.
Does a skincare brand need evidence before running an ad, or only if someone complains? Before. CAP Code Rule 3.7 requires marketers to hold documentary evidence for objective claims before a marketing communication is published or submitted, not after a challenge arrives.
Does writing compliant skincare copy mean writing weaker copy? No, usually the opposite. Vague claims read as generic marketing noise. Specific, evidence-backed appearance claims read as proof, and proof is what skincare shoppers are actually screening for in a crowded feed.
Is this article legal advice? No. This is general marketing guidance, not legal advice. A brand should get its specific claims reviewed by a qualified regulatory or legal adviser before publishing, particularly anything near the cosmetic/medicinal boundary.
Bottom line
A skincare brand doesn't have to choose between staying inside the ASA's rules and writing copy that actually sells. The two pull in the same direction, once the claim is built from real evidence and written as specifically as that evidence allows. We know what a skincare brand is allowed to claim in the UK, and we write copy that converts inside those lines.
Tell us about your business, and if it's a fit, the next step is a straight read on what your current copy is leaving on the table. If you want the wider picture first, here's how we run digital marketing end to end.